Monday, February 13, 2017

Early win means phase 3 test is on the way for Axovant's dementia drug | FierceBiotech


Positive results in a first crop of patients treated with its dementia drug have encouraged Axovant to start preparing for a phase 3 study.
http://bit.ly/2l1LIPm
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)